The role of the cowpox virus crmA gene during intratracheal and intradermal infection of C57BL/6 mice

Virology

Volumn 384, Issue 1, 2009, Pages 151-160

  MacNeill, A L ^a   Moldawer, L L ^b   Moyer, R W ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Attenuation of cowpox virus; Cowpox virus; crmA; Intradermal inoculation; Intratracheal inoculation; Mouse model of smallpox; Pathogenesis; Pneumonia; Poxvirus; Virulence factor

Indexed keywords

CYTOKINE RESPONSE MODIFIER A; IMMUNOMODULATING AGENT; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; C57BL 6 MOUSE; CELL INFILTRATION; COWPOX VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; INFECTION; INOCULATION; LUNG INFILTRATE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; CASPASES; COWPOX; COWPOX VIRUS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; MICE, INBRED C57BL; SERPINS; SMALLPOX; SPECIES SPECIFICITY; VIRAL PROTEINS; VIRULENCE;

COWPOX VIRUS; MUS; POXVIRIDAE; VARIOLA VIRUS;

EID: 58549095641     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.10.041     Document Type: Article

References (34)

1. Breman J.G., and Henderson D.A. Diagnosis and management of smallpox. N. Engl. J. Med. 346 (2002) 1300-1308
2. Chantrey J., Meyer H., Baxby D., Begon M., Bown K.J., Hazel S.M., et al. Cowpox: reservoir hosts and geographic range. Epidemiol. Infect. 122 (1999) 455-460
3. Chen C.H., Gobel T.W., Kubota T., and Cooper M.D. T cell development in the chicken. Poult. Sci. 73 (1994) 1012-1018
4. Dieli F., Lio D., Sireci G., and Salerno A. Genetic control of C3 production by the S region of the mouse MHC. J. Immunogenet. 15 (1988) 339-343
5. Fairchild G.A. Measurement of respiratory volume for virus retention studies in mice. Appl. Microbiol. 24 (1972) 812-818
6. Fenner F. Smallpox, "the most dreadful scourge of the human species." Its global spread and recent eradication. Med. J. Aust. 141 (1984) 841-846
7. Ferrier-Rembert A., Drillien R., Tournier J.N., Garin D., and Crance J.M. Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccines. Vaccine 25 (2007) 4809-4817
8. Garcia-Calvo M., Peterson E.P., Leiting B., Ruel R., Nicholson D.W., and Thornberry N.A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273 (1998) 32608-32613
9. Hawranek T., Tritscher M., Muss W.H., Jecel J., Nowotny N., Kolodziejek J., et al. Feline orthopoxvirus infection transmitted from cat to human. J. Am. Acad. Dermatol. 49 (2003) 513-518
10. Hayasaka D., Ennis F.A., and Terajima M. Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses. Virol. J. 4 (2007) 22
11. Janeway C.A., Travers P., Walport M., and Capra J.D. Immunobiology (1999), Garland Publishing, New York
12. Kettle S., Blake N.W., Law K.M., and Smith G.L. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology 206 (1995) 136-147
13. Kettle S., Alcami A., Khanna A., Ehret R., Jassoy C., and Smith G.L. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF- and fas-mediated apoptosis, but does not prevent IL-1 beta-induced fever. J. Gen. Virol. 78 (1997) 677-685
14. Khan S.S., Smith M.S., Reda D., Suffredini A.F., and McCoy Jr. J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin. Cytom. 61 (2004) 35-39
15. Knorr C.W., Allen S.D., Torres A.R., and Smee D.F. Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection. Antivir. Res. 72 (2006) 125-133
16. Legrand F.A., Verardi P.H., Jones L.A., Chan K.S., Peng Y., and Yilma T.D. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. J. Virol. 78 (2004) 2770-2779
17. Lewis-Jones S. Zoonotic poxvirus infections in humans. Curr. Opin. Infect. Dis. 17 (2004) 81-89
18. Martin D.B. The cause of death in smallpox: an examination of the pathology record. Mil. Med. 167 (2002) 546-551
19. Martinez M.J., Bray M.P., and Huggins J.W. A mouse model of aerosol-transmitted orthopoxviral disease - morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system. Arch. Pathol. Lab. Med. 124 (2000) 362-377
20. Masteller E.L., Pharr G.T., Funk P.E., and Thompson C.B. Avian B cell development. Int. Rev. Immunol. 15 (1997) 185-206
21. Melamed S., Paran N., Katz L., Ben-Nathan D., Israely T., Schneider P., Lenin R., and Lustig S. Tail scarification with vaccinia virus lister as a model for evaluation of smallpox vaccine potency in mice. Vaccine 25 (2007) 7743-7753
22. Nathaniel R., MacNeill A.L., Wang Y.X., Turner P.C., and Moyer R.W. Cowpox virus CrmA, myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J. Gen. Virol. 85 (2004) 1267-1278
23. Nitsche A., Gelderblom H.R., Eisendle K., Romani N., and Pauli G. Pitfalls in diagnosing human poxvirus infections. J. Clin. Virol. 38 (2007) 165-168
24. Palumbo G.J., Buller R.M., and Glasgow W.C. Multigenic evasion of inflammation by poxviruses. J. Virol. 68 (1994) 1737-1749
25. Pickup D.J., Ink B.S., Parsons B.L., Hu W., and Joklik W.K. Spontaneous deletions and duplications of sequences in the genome of cowpox virus. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 6817-6821
26. Quan L.T., Caputo A., Bleackley R.C., Pickup D.J., and Salvesen G.S. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem. 270 (1995) 10377-10379
27. Ray C.A., and Pickup D.J. The mode of death of pig kidney cells infected with cowpox virus is governed by the expression of the crmA gene. Virology 217 (1996) 384-391
28. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69 (1992) 597-604
29. Reading P.C., and Smith G.L. A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J. Gen. Virol. 84 (2003) 1973-1983
30. Reed L.T., and Muench H.A. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) 493-497
31. Smith G.L., Howard S.T., and Chan Y.S. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. J. Gen. Virol. 70 Pt 9 (1989) 2333-2343
32. Thompson J.P., Turner P.C., Ali A.N., Crenshaw B.C., and Moyer R.W. The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice. Virology 197 (1993) 328-338
33. Tscharke D.C., Reading P.C., and Smith G.L. Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J. Gen. Virol. 83 (2002) 1977-1986
34. Zhou Q., Snipas S., Orth K., Muzio M., Dixit V.M., and Salvesen G.S. Target protease specificity of the viral serpin CrmA - analysis of five caspases. J. Biol. Chem. 272 (1997) 7797-7800